Bromodomain proteins as potential therapeutic targets for B-cell non-Hodgkin lymphoma
{{output}}
Background: B-cell non-Hodgkin lymphoma (B-NHL) is the most common type of lymphoma and is significantly heterogeneous among various subtypes. Despite of considerable advancements in treatment strategies for B-NHL, the prognosis ... ...
